Zirconium Zr 89-Df-Crefmirlimab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 89Zr-Crefmirlimab Berdoxam, 89Zr-Desferrioxamine-IAB22M2C, 89Zr-Df-Crefmirlimab, 89Zr-Df-IAB22M2C, ZIRCONIUM ZR-89-DESFERRIOXAMINE-IAB22M2C, Zirconium Zr 89-Df-IAB22M2C

Filter by location:

Duarte, California1 trial

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.